Creative Planning’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-271
Closed -$187K – 2046
2018
Q3
$187K Hold
271
– – ﹤0.01% 1693
2018
Q2
$88K Buy
+271
New +$117K ﹤0.01% 1790
2017
Q4
– Sell
-50
Closed -$49K – 1972
2017
Q3
$49K Hold
50
– – ﹤0.01% 1778
2017
Q2
$63K Hold
50
– – ﹤0.01% 2331
2017
Q1
$103K Buy
+50
New +$122K ﹤0.01% 1936

Other funds holding MTNB

Creative Planning's MTNB Position: Q4 2018 in Review

Creative Planning sold out of Matinas BioPharma (MTNB) in Q4 2018, closing a stake of 271 shares — an estimated $187K sold.

Creative Planning first reported a position in MTNB in Q1 2017 and held it in 5 quarters. The position peaked at $187K in Q3 2018. 34 funds tracked by Wall St. Rank hold MTNB as of Q4 2018.

  • Creative Planning reported no remaining Matinas BioPharma position as of Q4 2018 after selling out during the quarter.
  • Creative Planning sold 271 Matinas BioPharma shares in Q4 2018, an estimated $187K.
  • Creative Planning first reported a position in Matinas BioPharma in Q1 2017 and held it in 5 quarters.
  • Creative Planning's Matinas BioPharma position peaked at $187K in Q3 2018.
  • 34 funds tracked by Wall St. Rank held Matinas BioPharma as of Q4 2018.

Based on Creative Planning's 13F filing for Q4 2018, filed 1 Feb 2019.